Cite
HARVARD Citation
Nee, J. et al. (2019). Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysis. Expert review of gastroenterology & hepatology. pp. 397-406. [Online].